2021 NFID Influenza/Pneumococcal Disease News Conference

The nation’s leading infectious disease experts shared results from a new national survey of US adults to better understand attitudes and behaviors about COVID-19, influenza, and pneumococcal disease at the 2021 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Thursday, October 7, 2021. Rochelle P. Walensky, MD, Centers for Disease Control and Prevention (CDC) Director, presented final influenza vaccine coverage data from the 2020-2021 season and discussed the importance of vaccination to prevent flu and pneumococcal disease.

Panelists for the event included NFID Medical Director William Schaffner, MD (moderator); Laura E. Riley, MD, obstetrician and gynecologist-in-chief, NewYork-Presbyterian/Weill Cornell Medical Center and chair, Department of Obstetrics and Gynecology, Weill Cornell Medicine; Cedric “Jamie” Rutland, MD, CEO of West Coast Lung and COVID-19 medical director, Private Health Management; and NFID President-Elect Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, pediatric nurse practitioner, Children’s Minnesota (retired) and affiliate faculty, School of Nursing, University of Minnesota.

Press Release

News Conference Agenda

Panelist Bios

National Survey: Attitudes about Influenza, Pneumococcal Disease, and COVID-19

Influenza Vaccine Coverage by Population

Leading By Example: NFID initiative calling on leaders in healthcare, business, education, and politics to lead by example by making a commitment to flu prevention. Organizations can join the growing list of supporters and participate in activities to show their support of annual flu vaccination.